Potential effect of the gut microbiome on tumour response to anti-cancer treatment in patients diagnosed with pancreatic ductal adenocarcinoma. This is an ASCO Meeting Abstract from the 2025 ASCO ...

Discover new treatments currently being developed for pancreatic cancer, which has historically been extremely difficult to ...

Genomic analysis of paired primary and metastatic pancreatic ductal adenocarcinoma tumors.

By Dr. Sanchari Sinha Dutta, Ph.D. New research uncovers how distinct molecular profiles and immune signatures in metastatic pancreatic cancer impact survival and guide tailored treatment strategies.

Managing weight loss with telotristat ethyl in patients with metastatic pancreatic ductal adenocarcinoma may improve survival ...

Baseline geriatric assessment vulnerabilities and quality of life scores correlate with overall survival in patients with ...

Alligator Bioscience has announced positive outcomes from indirect treatment comparison studies, showing that mitazalimab ...

Alexander I. Spira, MD, PhD, FACP, discusses the clinical implications of ctDNA for treatment decisions and monitoring in ...

Pancreatic ductal adenocarcinoma (PDAC) is an aggressive malignancy characterized by distinct histological subtypes and a poor prognosis. Among these, the micropapillary pattern, typically observed ...

By Daniella Parra Lisata Therapeutics said results from Cohort A of its Phase 2 ASCEND trial showed complete responses in 6.2% of certepetide-treated patients, compared to 0% in the placebo group. The ...